U.S. markets open in 2 hours 38 minutes
  • S&P Futures

    3,682.50
    +28.25 (+0.77%)
     
  • Dow Futures

    29,469.00
    +184.00 (+0.63%)
     
  • Nasdaq Futures

    11,307.00
    +78.75 (+0.70%)
     
  • Russell 2000 Futures

    1,699.10
    +17.00 (+1.01%)
     
  • Crude Oil

    81.36
    +0.13 (+0.16%)
     
  • Gold

    1,673.80
    +5.20 (+0.31%)
     
  • Silver

    19.02
    +0.31 (+1.67%)
     
  • EUR/USD

    0.9763
    -0.0057 (-0.58%)
     
  • 10-Yr Bond

    3.7470
    0.0000 (0.00%)
     
  • Vix

    30.89
    +0.71 (+2.35%)
     
  • GBP/USD

    1.1082
    -0.0042 (-0.37%)
     
  • USD/JPY

    144.4890
    +0.0460 (+0.03%)
     
  • BTC-USD

    19,494.56
    +59.57 (+0.31%)
     
  • CMC Crypto 200

    445.95
    -0.03 (-0.01%)
     
  • FTSE 100

    6,927.27
    +45.68 (+0.66%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

Dentsply Sirona Expects Q2 Sales of Over $1B, To Miss Quarterly Filing Deadline

·1 min read
  • Dentsply Sirona Inc (NASDAQ: XRAY) expects to report Q2 FY22 net sales of over $1.01 billion. Additionally, diluted EPS is expected to be at or above $0.26 and adjusted EPS at or above $0.60.

  • The company said that though sales declined Y/Y due to the unfavorable impact of foreign exchange, the business delivered organic sales growth driven by solid European regional performance and demand in CAD/CAM, Equipment & Instruments, and Restorative and Preventive Consumables.

  • The company continued to experience macro headwinds, including ongoing supply shortages and softness in sales in China due to COVID-related shutdowns.

  • Related: Moderna Justifies It Did Not Know About Investigation On Its New CFO.

  • Dentsply Sirona declared a quarterly cash dividend of $0.125 per share payable October 14 as of the record date of September 30.

  • As previously disclosed, the Audit Committee is conducting an internal investigation regarding certain financial reporting matters. XRAY expects it cannot file its Quarterly Report on Form 10-Q for the period ended June 30 by the August 9 deadline.

  • Price Action: XRAY shares are up 0.64% at $36.14 on the last check Friday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.